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A B S T R A C T
We report the first case of Myroides phaeus isolated from blood, causing bacteremia in an
immunocompromised patient using the automated MicroScan Walk Away 96 system, followed by
bacterial identification by amplification-sequencing of the 16S rDNA. The sequences obtained were
compared with the reference sequence of the BLAST 1 platform - National Library of Medicine, USA, and
the isolation was identified as Myroides phaeus strain with 99.67 % identity in Blast report. In the literature
we did not find previous reported cases of infections by this bacterium, however its pathogenic role is still
controversial; therefore, this isolation alerts us to carry out an exhaustive surveillance of other possible
acquisition routes.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The genus Myroides is a heterogeneous group of gram negative,
aerobic, non-fermenting, non-mobile bacilli. In 1996 Vancanneyt
et al. reclassified Flavobacterium odoratum into 2 different species:
Myroides odoratum and Myroides odoratimimus [1]. Both are
considered low-grade opportunistic pathogens that cause com-
munity-acquired and in-hospital infections, including urinary tract
infections, skin and soft tissue infections, bacteremia, pneumonia,
and intra-abdominal infections, most often described in immuno-
compromised hosts [2,3]. In recent years, 2 species that had not
previously been described as human pathogens, Myroides phaeus
isolated from saliva [4] and Myroides injenensis isolated from urine
[5] were isolated. We present the case of an immunosuppressed
patient, due to multiple myeloma in addition to chronic kidney
disease on hemodialysis who developed bacteremia due to
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A 57-year-old female patient with a history of high blood
pressure, diabetes mellitus for 4 months and chronic kidney
disease in renal replacement therapy (RRT). 8 years ago he was
diagnosed with multiple myeloma, so she received initial
treatment with thalidomide and dexamethasone cycles with
partial remission of the disease. Due to this, it was decided to
change the therapeutic scheme and start bortezomib (3 cycles),
treatment that she maintained until the current hospitalization.
For RRT, it required temporary catheter placement in the right
femoral vein, which would be replaced by a long-term catheter
within twenty days. The results of laboratory examinations at
admission indicated: leukocytes 3380/mm3, hemoglobin 7.5 g/dL,
platelets 190 000/mm3 and C-reactive protein 5.4 mg/L.
During the first hemodialysis session, fever rose to 38 C with
chills, so that a set of peripheral blood cultures and the femoral
catheter were obtained prior to the start of empirical antimicrobial
therapy with ceftazidime. At 24 h an increase in the acute phase
reactants (C-reactive protein 112.2 mg/L) was found, and the
microbiology laboratory reported the growth of slightly rough
white-yellowish colonies with gram negative staining; therefore
the temporary catheter was removed. The final report of thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2 G. Pérez-Lazo et al. / IDCases 19 (2020) e00695MicroScan Walk Away 96 automated equipment identified
Myroides sp, with the following susceptibility profile: amikacin
MIC > 32 (resistant), aztreonam MIC > 8 (resistant), cefepime
MIC > 8 (resistant), cefotaxime MIC > 16 (resistant), ceftazidime
MIC > 16 (resistant), ciprofloxacin MIC > 2 (resistant), gentamicin
MIC > 8 (resistant), imipenem MIC > 8 (resistant), levofloxacin
MIC > 4 (resistant), meropenem MIC > 8 (resistant), piperacillin-
tazobactam MIC < 16 (sensitive), tobramycin MIC > 8 (resistant),
trimethroprim-sulfamethoxazole MIC > 2/38 (resistant); there-
fore, it was decided to optimize the antimicrobial coverage with
piperacillin-tazobactam for 7 days at 96 h, with favorable evolution
and disappearance of the fever 48 h after the start of the targeted
antimicrobial treatment. The peripheral blood cultures at 48 h of
targeted therapy were negative. The patient was discharged with a
new catheter located in the left femoral vein.
The microbiological isolation and initial identification of the
strain of Myroides spp. was carried out by the MicroScan Walk
Away 96 automated system in the microbiology laboratory of the
Guillermo Almenara Irigoyen National Hospital. Subsequently, this
strain was sent to the Molecular Biology Laboratory of the Institute
of Nutritional Research, Lima-Peru. The 16S rDNA gene was
amplified by conventional PCR, from the DNA extracted from a pure
culture of the bacterium, the fragments were visualized on a 3 %
agarose gel (Fig. 1) and the amplified products were purified for
direct sequencing with the Sanger method (Macrogen1 Korea).
The sequences obtained were compared with the reference
sequence of the BLAST 1 platform - National Library of Medicine,
USA. Isolation was identified as Myroides phaeus strain (99.67 %
identity in Blast report).
Discussion
Myroides phaeus, is a bacterial species that was isolated from
human saliva from a Chinese student who was asymptomatic, the
phylogenetic analysis was close to Myroides marinus, Myroides
odoratimimus and Myroides profundi with similarity in genetic
sequences of 96.5 %, 96.3 % and 96.1 %, respectively [4]. So far, this
species has not been reported as a pathogen, and in general due to
the limited reports related to infections caused by Myroides, it is
not yet possible to determine the true role of this species as aFig. 1. The band My 01 and My 02 show the fragments amplified from the culture.human pathogen. Myroides spp. is commonly found in environ-
mental sources, particularly in soil and water, but also in
wastewater from hospitals [6,7].
The case of our patient is a catheter-associated bacteremia in an
immunocompromised host, with diabetes and chronic kidney
disease in hemodialysis. Myroides spp. infections have been
described receiving these risk groups, but the contamination
scenario is also possible during venipuncture, in the preparation of
the culture media or during the processing of the culture, which
could be considered as pseudobacteremia [8]. Although this
possibility is present, the application of standardized protocols for
sampling and processing, as well as biosecurity, make the
contamination introduced at any stage of the blood culture, from
extraction to processing in the laboratory, to a minimum.
In the report by Douce et al. isolates of Myroides odoratus were
described in peripheral blood and central venous catheter samples,
related to contaminated injection water in a hospital in Ecuador,
however, they were not considered as pathogenic agents [9].
Another report documented urinary tract infection with Myroides
odoratimimus in an elderly patient [10]. However, in the Americas
there have been eight reports of clinical isolates, one in Jamaica
associated with endocarditis and bacteremia in a hemodialysis
patient, also in Argentina and six cases in the United States
[2,11,12]. In the scientific literature, so far there are no reports of
isolates of the Myroides genus in Peru, and Myroides phaeus has not
been reported as a cause of bacteremia or any other infectious
process.
The identification of Myroides by automated methods such as
MicroScan Panel or VITEK 2 have limitations in the identification of
species, in contrast both MALDI-TOF MS and 16S rDNA sequencing
allow to differentiate Myroides odoratimimus, Myroides odoratus
and other species of the genus Myroides [2,13]. In addition, the
relevance of this species is that most strains are resistant to
multiple drugs, and have various virulence factors such as their
ability to form biofilms [14]. The strain isolated in this case only
showed susceptibility to piperacillin-tazobactam. The sensitivity
to this antimicrobial drug is variable in the strains of Myroides
odoratimimus and Myroides odoratum [15].
In conclusion, we report the first case of Myroides phaeus
isolated in blood culture, causing bacteremia in an immunocom-
promised patient using MicroScan Panel in addition to PCR –
genetic sequencing. More studies are needed to determine the
relevance of M. phaeus as a pathogen.
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